Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) traded down 10.3% on Wednesday . The company traded as low as $3.25 and last traded at $3.50. 850 shares changed hands during trading, a decline of 91% from the average session volume of 9,053 shares. The stock had previously closed at $3.90.
Peak Pharmaceuticals Price Performance
The stock’s fifty day simple moving average is $4.84 and its 200-day simple moving average is $2.63.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Read More
- Five stocks we like better than Peak Pharmaceuticals
- Stock Splits, Do They Really Impact Investors?
- JPMorgan is a Buy, if You Can Handle The Volatility
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- United States Steel’s Crash: An Unmissable Buying Opportunity
- Want to Profit on the Downtrend? Downtrends, Explained.
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
